The artificial pancreas (AP) is a closed-loop system to automatically regulate the glucose concentration in patients with type 1 diabetes (T1D). Model predictive control (MPC) revealed to be one of the most promising approaches for this control problem. Several MPC algorithms have been tested in clinical trials with satisfactorily results. However, the inter-patient variability characterising T1D patients limits the performance of MPC algorithms synthesized on average models and calls for patient-tailored models. The availability of experimental data on long outpatient trials motivated the study of identification techniques applicable to free-living patient data. Moreover, a detailed data analysis can be used to improve model identification...
Diabetes is a growing chronic disease and a worldwide problem. Without any available cure in sight f...
In the last decade, control algorithms designed for Artificial Pancreas (AP) systems were characteri...
People with type 1 diabetes (T1D) face the challenge of administering exogenous insulin to maintain ...
Objective: Contemporary and future outpatient long-term artificial pancreas (AP) studies need to cop...
Background The technological advancements in subcutaneous continuous glucose monitoring and insulin ...
Background: The objective of this research is to develop a new artificial pancreas that takes into a...
BACKGROUND: The objective of this research is to develop a new artificial pancreas that takes into ...
Postprandial characterization of patients with type 1 diabetes is crucial for the development of an ...
Hypoglycaemia avoidance is one of the main barriers to the optimal management of Type 1 Diabetes (T1...
This paper addresses the design of glucose regulators based on Model Predictive Control (MPC) to be ...
Despite the continuous efforts devoted to AP development in the last decades, an artificial pancreas...
The identification of patient-tailored linear time invariant glucose-insulin models is investigated ...
Inpatient studies suggest that model predictive control (MPC) is one of the most promising algorithm...
BACKGROUND: The development of artificial pancreas has received a new impulse from recent technolog...
In the last years, Model Predictive Control (MPC) proved to be one of the most promising approaches ...
Diabetes is a growing chronic disease and a worldwide problem. Without any available cure in sight f...
In the last decade, control algorithms designed for Artificial Pancreas (AP) systems were characteri...
People with type 1 diabetes (T1D) face the challenge of administering exogenous insulin to maintain ...
Objective: Contemporary and future outpatient long-term artificial pancreas (AP) studies need to cop...
Background The technological advancements in subcutaneous continuous glucose monitoring and insulin ...
Background: The objective of this research is to develop a new artificial pancreas that takes into a...
BACKGROUND: The objective of this research is to develop a new artificial pancreas that takes into ...
Postprandial characterization of patients with type 1 diabetes is crucial for the development of an ...
Hypoglycaemia avoidance is one of the main barriers to the optimal management of Type 1 Diabetes (T1...
This paper addresses the design of glucose regulators based on Model Predictive Control (MPC) to be ...
Despite the continuous efforts devoted to AP development in the last decades, an artificial pancreas...
The identification of patient-tailored linear time invariant glucose-insulin models is investigated ...
Inpatient studies suggest that model predictive control (MPC) is one of the most promising algorithm...
BACKGROUND: The development of artificial pancreas has received a new impulse from recent technolog...
In the last years, Model Predictive Control (MPC) proved to be one of the most promising approaches ...
Diabetes is a growing chronic disease and a worldwide problem. Without any available cure in sight f...
In the last decade, control algorithms designed for Artificial Pancreas (AP) systems were characteri...
People with type 1 diabetes (T1D) face the challenge of administering exogenous insulin to maintain ...